Vertex Pharmaceuticals
VRTX
#171
Rank
$82.51 B
Marketcap
$321.45
Share price
0.13%
Change (1 day)
40.85%
Change (1 year)

P/E ratio for Vertex Pharmaceuticals (VRTX)

P/E ratio as of January 2023 (TTM): 25.2

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.1835. At the end of 2021 the company had a P/E ratio of 24.1.

P/E ratio history for Vertex Pharmaceuticals from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202124.16.4%
202022.7-52.66%
201947.9138.24%
201820.1-85.64%
2017140-189.35%
2016-157187.75%
2015-54.543.97%
2014-37.83.88%
2013-36.4-57.41%
2012-85.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
23.2-7.98%๐Ÿ‡บ๐Ÿ‡ธ USA
19.4-22.92%๐Ÿ‡บ๐Ÿ‡ธ USA
31.5 25.18%๐Ÿ‡บ๐Ÿ‡ธ USA
17.5-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
23.3-7.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.78-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.